Brought to you by 
Moderna raises $110mm in second financing round
26 Nov 2013
Executive Summary
Messenger RNA company Moderna Therapeutics Inc. raised $110mm through what appears to be the company's Series B round. The financing came from 39 undisclosed private investors, a large syndicate that EBI assumes includes the company's only published investor--Flagship Ventures. Moderna has now raked in $415mm in cash in just one year: a $40mm first round in December 2012; $240mm up front from AstraZeneca as part of a 40-project licensing deal signed in March; a $25mm grant from the Defense Advanced Research Projects Agency in October; and the current $110mm financing.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Moderna raises $110mm in second financing round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice